Literature DB >> 25123350

From hundreds to thousands: Widening the normal human Urinome (1).

Laura Santucci1, Giovanni Candiano1, Andrea Petretto2, Maurizio Bruschi1, Chiara Lavarello2, Elvira Inglese2, Pier Giorgio Righetti3, Gian Marco Ghiggeri4.   

Abstract

It is currently unknown how many proteins can be detected in urine. Improving the analytical approach would increase their number and potentially strengthen their predictive potential in diseases. We developed a combination of analytical procedures for maximizing sensitivity and reproducibility of normal human urinary proteome analysis based on ultracentrifugation, vesicles separation, combinatorial peptide ligand libraries (CPLL) and solvent removal of pigments. Proteins were identified by an Orbitrap Velos Mass Spectrometry. Overall, 3429 proteins were characterized: most components (1615) were contained in vesicles while the remaining 1794 were equally distributed among CPLL and butanol insoluble fractions. Several proteins were detected exclusively in one of the phases of the procedure, suggesting that each step is crucial in the fractionation strategy. Many (1724) proteins are described here whose presence in urine has never been reported and represents a potential source of information considering that urine is the unique site of excretion of products of interaction of metabolic processes. Improving the characterization of normal urinary proteome would also represent the basis for the analysis of urine biomarkers in human diseases. BIOLOGICAL SIGNIFICANCE: Sub-fractionating normal urine by successive steps (vesicle separation, CPLL and solvent treatments) allowed the identification of 3429 proteins, a relevant part (1724) being detected for the first time in urine. Several proteins of new description have been implicated in physiology pathways and in pathologies thus representing a potential source of new information on both metabolic processes and diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Combinatorial peptide ligand libraries; Mass spectrometry; Urinary proteome; Vesicles

Mesh:

Substances:

Year:  2014        PMID: 25123350     DOI: 10.1016/j.jprot.2014.07.021

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  19 in total

1.  Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.

Authors:  Ellen R Brooks; Bernd Hoppe; Dawn S Milliner; Eduardo Salido; John Rim; Leah M Krevitt; Julie B Olson; Heather E Price; Gulsah Vural; Craig B Langman
Journal:  Am J Nephrol       Date:  2016-05-03       Impact factor: 3.754

Review 2.  Proteomics and autoimmune kidney disease.

Authors:  Brad H Rovin; Jon B Klein
Journal:  Clin Immunol       Date:  2015-05-13       Impact factor: 3.969

Review 3.  Current state of the art for enhancing urine biomarker discovery.

Authors:  Michael Harpole; Justin Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2016-06       Impact factor: 3.940

Review 4.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

5.  Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling.

Authors:  Ling Hao; Samuel Thomas; Tyler Greer; Chad M Vezina; Sagar Bajpai; Arya Ashok; Angelo M De Marzo; Charles J Bieberich; Lingjun Li; William A Ricke
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-17

Review 6.  Biomarker discovery in mass spectrometry-based urinary proteomics.

Authors:  Samuel Thomas; Ling Hao; William A Ricke; Lingjun Li
Journal:  Proteomics Clin Appl       Date:  2016-02-11       Impact factor: 3.494

7.  Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles.

Authors:  Uta Erdbrügger; Charles J Blijdorp; Irene V Bijnsdorp; Francesc E Borràs; Dylan Burger; Benedetta Bussolati; James Brian Byrd; Aled Clayton; James W Dear; Juan M Falcón-Pérez; Cristina Grange; Andrew F Hill; Harry Holthöfer; Ewout J Hoorn; Guido Jenster; Connie R Jimenez; Kerstin Junker; John Klein; Mark A Knepper; Erik H Koritzinsky; James M Luther; Metka Lenassi; Janne Leivo; Inge Mertens; Luca Musante; Eline Oeyen; Maija Puhka; Martin E van Royen; Catherine Sánchez; Carolina Soekmadji; Visith Thongboonkerd; Volkert van Steijn; Gerald Verhaegh; Jason P Webber; Kenneth Witwer; Peter S T Yuen; Lei Zheng; Alicia Llorente; Elena S Martens-Uzunova
Journal:  J Extracell Vesicles       Date:  2021-05-21

Review 8.  Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics.

Authors:  Yi-Ting Chen; Cheng-Han Tsai; Chien-Lun Chen; Jau-Song Yu; Ying-Hsu Chang
Journal:  J Food Drug Anal       Date:  2018-10-27       Impact factor: 6.157

9.  From hundreds to thousands: Widening the normal human Urinome.

Authors:  Laura Santucci; Giovanni Candiano; Andrea Petretto; Maurizio Bruschi; Chiara Lavarello; Elvira Inglese; Pier Giorgio Righetti; Gian Marco Ghiggeri
Journal:  Data Brief       Date:  2014-08-22

Review 10.  Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal Urine.

Authors:  Laura Santucci; Maurizio Bruschi; Giovanni Candiano; Francesca Lugani; Andrea Petretto; Alice Bonanni; Gian Marco Ghiggeri
Journal:  Biomark Insights       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.